This indicated that resveratrol-mediated p38 MAPK activation might repress the expression of FOXO3a, and thereby reduce levels of SOD2 and catalase, enhance pro-apoptosis gene expression, and repress anti-apoptosis genes expression, leading to apoptosis in BPH-1 cells. The gene discussed is SOD2; the disease is benign prostatic hyperplasia.